FCM
BSX icon

Fieldview Capital Management’s Boston Scientific BSX Stock Holding History

Fieldview Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$930K Buy
+14,815
New +$1.19M 0.27% 116
2025
Q4 		– Sell
-54,715
Closed -$5.34M – 495
2025
Q3 		$5.34M Buy
+54,715
New +$5.67M 0.87% 11

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fieldview Capital Management's BSX Position: Q1 2026 in Review

Fieldview Capital Management opened a new position in Boston Scientific (BSX) in Q1 2026: 14,815 shares worth $930K. The stake represents 0.27% of the portfolio and ranks #116 among its holdings. This is a return to the name: Fieldview Capital Management previously reported a position in BSX as recently as Q3 2025.

Fieldview Capital Management first reported a position in BSX in Q3 2025 and has held it in 2 quarters since. The position peaked at $5.34M in Q3 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Fieldview Capital Management held 14,815 shares of Boston Scientific worth $930K as of Q1 2026.
  • Boston Scientific was a new Fieldview Capital Management position in Q1 2026.
  • Boston Scientific made up 0.27% of Fieldview Capital Management's portfolio in Q1 2026, its #116 holding.
  • Fieldview Capital Management first reported a position in Boston Scientific in Q3 2025 and has held it in 2 quarters since.
  • Fieldview Capital Management's Boston Scientific position peaked at $5.34M in Q3 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Fieldview Capital Management's 13F filing for Q1 2026, filed 14 May 2026.